IMMIX BIOPHARMA
Live / Registered — Registered (as of 05 Dec 2023)
What this means for you
Registered since 05 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97645177
- Registration number
- 7234591
- Mark type
- Stylized text
- Filed
- 24 Oct 2022
- Published for opposition
- 19 Sept 2023
- Registered
- 05 Dec 2023
- Attorney of record
- Sheila R. Gibson
Goods and services
- Class 042 — Scientific and technological services: scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulated diseases; research and development services in the field of anti-cancer preparations; research and development services in the field of preparations for treating immuno-dysregulated diseases; pharmaceutical drug design, product engineering, pharmaceutical research, pharmaceutical drug development and pharmaceutical product quality testing services for others in the field of oncology; pharmaceutical drug design, product engineering, pharmaceutical research, pharmaceutical drug development and pharmaceutical product quality testing services for others in the field of immuno-dysregulated diseases; providing information regarding medical research relating to oncology; providing information regarding medical research relating to immuno-dysregulated diseases
- Class 044 — Medical, beauty and agricultural services: providing medical information about the treatment of cancer; providing medical information about the treatment of immuno-dysregulated diseases; providing a website featuring healthcare and medical information, namely, information about cancer and the treatment of cancer; providing a website featuring healthcare and medical information, namely, information about immuno-dysregulated diseases and the treatment of immuno-dysregulated diseases
Owner
- Immix Biopharma, Inc., Los Angeles, CA, US
- Immix Biopharma, Inc., Los Angeles, CA, US
- Immix Biopharma, Inc., Los Angeles, CA, US
Prosecution history
- 05 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 19 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Sept 2023 — PUBLISHED FOR OPPOSITION
- 30 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Aug 2023 — EXAMINER'S AMENDMENT ENTERED
- 10 Aug 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Aug 2023 — EXAMINERS AMENDMENT E-MAILED
- 10 Aug 2023 — EXAMINERS AMENDMENT -WRITTEN
- 07 Aug 2023 — ASSIGNED TO EXAMINER
- 07 Nov 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Oct 2022 — NEW APPLICATION ENTERED